Market open
$
162.97
Change
+0.29 +0.18%
Volume
Volume 438,906
Apr 21, 2021, 12:12 p.m.
Real time quotes
Previous close
$ 162.68
$ 162.97
Change
+0.29 +0.18%
Day low
Day high
$162.29
$163.77

52 week low
52 week high
$85.45
$163.77

Market cap
$10.50B
Average volume
968,516
P/E ratio
53.68
Rev. per Employee
$175,877
EPS
3.04
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on PRAH
-
PRA Health Sciences stock price target raised to $155 from $110 at Mizuho
- Tomi Kilgore
-
PRA Health Sciences downgraded to sector weight from overweight at KeyBanc Capital
- Tomi Kilgore
-
PRA Health shares up 17% premarket
- Ciara Linnane
-
Icon expects deal to boost earnings in first full year and by 20% plus after that
- Ciara Linnane
-
Icon expects deal to close in Q3
- Ciara Linnane
-
Icon agrees to acquire PRA Health Sciences in cash and stock deal valued at about $12 bln
- Ciara Linnane
-
10 Hidden Gems in the Rush for Covid-Vaccine Stocks
- Barron's Online
-
PRA Health Sciences stock price target raised to $128 from $103 at SunTrust RH
- Tomi Kilgore
-
PRA Health Sciences upgraded to overweight from sector weight at KeyBanc Capital
- Tomi Kilgore
-
PRA Health Sciences started at market perform with $105 stock price target at SVB Leerink
- Tomi Kilgore
-
PRA Health Sciences downgraded to sector weight from overweight at KeyBanc Capital
- Tomi Kilgore
-
PRA Health Sciences started at neutral with $115 stock price target at UBS
- Tomi Kilgore
-
KKR's profit falls as private-equity gains slow
- MarketWatch.com
-
PRA Health Sciences started at outperform with $89 stock price target at Raymond James
- Tomi Kilgore
-
PRA Health Sciences stock price target raised to $86 from $80 at KeyBanc Capital
- Tomi Kilgore
-
PRA Health stock price target raised to $72 from $68 at Pacific Crest
- Tomi Kilgore
-
PRA Health Sciences stock price target raised to $67 from $50 at Credit Suisse
- Tomi Kilgore
- Loading more headlines...
Analyst Ratings
Other News on PRAH
-
Icon wins U.S. antitrust approval for PRA Health acquisition
- Seeking Alpha
-
Syneos Health gains following Thermo Fisher $17B deal for PPD
- Seeking Alpha
-
Thermo Fisher Nears Deal to Buy PPD for More Than $15 Billion
- Jonathan D. Rockoff
-
PPD gains after report Thermo Fisher nearing $15B deal
- Seeking Alpha
-
Wells Fargo upgrades ICON to overweight, sees ~20% upside
- Seeking Alpha
-
Companies Offer Investors a Glimpse at Employee Turnover
- Mark Maurer
- Loading more headlines...
Press Releases on PRAH
-
Peter Windisch Appointed Chief Technology Officer at Excelya
- BusinessWire - BZX
-
Technologies in the Emerging Contract Research Organization Services Market 2020-2027
- Market Insight Reports
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com